Pasar al contenido principal

EL DOMINIO INTRINSECAMENTE DESORDENADO DE TRANSACTIVACION DEL RECEPTOR DE ANDROGENOS COMO DIANA FARMACOLOGICA

BIO2012-31043

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2012
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Secretaría de Estado de Investigación, Desarrollo e Innovación
Centro beneficiario FUNDACIO INSTITUT DE RECERCA BIOMEDICA (BARCELONA)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Regulation of androgen receptor activity by transient interactions of its transactivation domain with general transcription regulators

  • De Mol, Eva
  • Szulc, Elzbieta
  • Di Sanza, Claudio
  • Martínez-Cristóbal, Paula
  • Bertoncini, Carlos W.
  • Fenwick, R. Bryn
  • Frigolé-Vivas, Marta
  • Masín, Marianela
  • Hunter, Irene
  • Buzón, Víctor
  • Brun-Heath, Isabelle
  • García, Jesús
  • De Fabritiis, Gianni
  • Estébanez-Perpiñá, Eva
  • McEwan, Iain J.
  • Nebreda, Ángel R.
  • Salvatella, Xavier
The androgen receptor is a transcription factor that plays a key role in the development of prostate cancer, and its interactions with general transcription regulators are therefore of potential therapeutic interest. The mechanistic basis of these interactions is poorly understood due to the intrinsically disordered nature of the transactivation domain of the androgen receptor and the generally transient nature of the protein-protein interactions that trigger transcription. Here, we identify a motif of the transactivation domain that contributes to transcriptional activity by recruiting the C-terminal domain of subunit 1 of the general transcription regulator TFIIF. These findings provide molecular insights into the regulation of androgen receptor function and suggest strategies for treating castration-resistant prostate cancer., This work was supported by IRB, ICREA (X.S.), Obra Social “la Caixa” (E.D.M., E.S., and X.S.), MINECO (BIO2012-31043 and BIO2015-70092-R to X.S., BIO2014-53095-P to G.D.F.), Marató de TV3 (102030 to X.S. and 102031 to E.E.-P), the COFUND program of the European Commission (C.D.S.), the European Research Council (CONCERT, contract number 648201 to X.S.), the Ramón y Cajal program of MICINN (RYC-2011-07873 to C.W.B.), the Serra Hunter Program (E.E.-P.), AGAUR (SGR-2014-56RR14 to E.E.-P), and FEDER (G.D.F.). I.H. was supported by funding from the Chief Scientist's Office of the Scottish Government (ETM-258, ETM-382). IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Regulation of androgen receptor activity by transient interactions of its transactivation domain with general transcription regulators

  • De Mol, Eva
  • Szulc, Elzbieta
  • Di Sanza, Claudio
  • Martínez-Cristóbal, Paula
  • Bertoncini, Carlos W.
  • Fenwick, R. Bryn
  • Frigolé-Vivas, Marta
  • Masín, Marianela
  • Hunter, Irene
  • Buzón, Víctor
  • Brun-Heath, Isabelle
  • García, Jesús
  • De Fabritiis, Gianni
  • Estébanez-Perpiñá, Eva
  • McEwan, Iain J.
  • Nebreda, Ángel R.
  • Salvatella, Xavier
The androgen receptor is a transcription factor that plays a key role in the development of prostate cancer, and its interactions with general transcription regulators are therefore of potential therapeutic interest. The mechanistic basis of these interactions is poorly understood due to the intrinsically disordered nature of the transactivation domain of the androgen receptor and the generally transient nature of the protein-protein interactions that trigger transcription. Here, we identify a motif of the transactivation domain that contributes to transcriptional activity by recruiting the C-terminal domain of subunit 1 of the general transcription regulator TFIIF. These findings provide molecular insights into the regulation of androgen receptor function and suggest strategies for treating castration-resistant prostate cancer., This work was supported by IRB, ICREA (X.S.), Obra Social “la Caixa” (E.D.M., E.S., and X.S.), MINECO (BIO2012-31043 and BIO2015-70092-R to X.S., BIO2014-53095-P to G.D.F.), Marató de TV3 (102030 to X.S. and 102031 to E.E.-P), the COFUND program of the European Commission (C.D.S.), the European Research Council (CONCERT, contract number 648201 to X.S.), the Ramón y Cajal program of MICINN (RYC-2011-07873 to C.W.B.), the Serra Hunter Program (E.E.-P.), AGAUR (SGR-2014-56RR14 to E.E.-P), and FEDER (G.D.F.). I.H. was supported by funding from the Chief Scientist's Office of the Scottish Government (ETM-258, ETM-382). IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

hnRNPDL phase separation is regulated by alternative splicing and disease-causing mutations accelerate its aggregation

  • Batlle Carreras, Cristina|||0000-0003-4903-831X
  • Yang, Peiguo
  • Coughlin, Maura
  • Messing, James
  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Szulc, Elzbieta
  • Salvatella, Xavier|||0000-0002-8371-4185
  • Kim, Hong Joo
  • Taylor, J. Paul
  • Ventura, Salvador|||0000-0002-9652-6351
Prion-like proteins form multivalent assemblies and phase separate into membraneless organelles. Heterogeneous ribonucleoprotein D-like (hnRNPDL) is a RNA-processing prion-like protein with three alternative splicing (AS) isoforms, which lack none, one, or both of its two disordered domains. It has been suggested that AS might regulate the assembly properties of RNA-processing proteins by controlling the incorporation of multivalent disordered regions in the isoforms. This, in turn, would modulate their activity in the downstream splicing program. Here, we demonstrate that AS controls the phase separation of hnRNPDL, as well as the size and dynamics of its nuclear complexes, its nucleus-cytoplasm shuttling, and amyloidogenicity. Mutation of the highly conserved D378 in the disordered C-terminal prion-like domain of hnRNPDL causes limb-girdle muscular dystrophy 1G. We show that D378H/N disease mutations impact hnRNPDL assembly properties, accelerating aggregation and dramatically reducing the protein solubility in the muscle of Drosophila, suggesting a genetic loss-of-function mechanism for this muscular disorder.